TAFAZZIN and Barth syndrome: Thus, characterization efforts in Taz-KO mice have largely addressed only the clinical triad of BTHS, while other significant symptoms in patients such as growth delay, altered substrate metabolism and whole-body energetics, and impaired physical activity have not yet been investigated or considered in the context of aging.